clinical trials

Recent Rosacea Blog Posts

Mirvaso Gel Judged Safe and Efficacious Long Term

This just published paper, in the peer-reviewed Journal of Drugs in Dermatology, again asserts that Mirvaso is “efficacious and safe“ for daily use over 1 year. This study details a trial of 345 users over a year, whilst the Mirvaso Prescribing Information quotes results from 276 users over 1 year. The previously published long term […]

Continue Reading

Anatabloc Cream helps moderate rosacea

We first heard about Anatabloc Cream (Antabine) a year ago when Rock Creek Pharmaceuticals listed a clinical trial to assess the safety and effects of Anatabine in the appearance of rosacea symptoms. Now the clinical trial results have been written up in an article in Case Reports in Dermatology. The results are modest, but encouraging […]

Continue Reading

DRM02 (topical kinase inhibitor) for lesions of Rosacea

A new topical, being called DRM02 has been listed at ClinicalTrials as being investigated as safe and effective for the lesions of rosacea. ClinicalTrials is one way that rosacea sufferers find out about new potential treatments that are undergoing early clinical trials. What is DRM02? I know that each time I see a new trial […]

Continue Reading

Treating Redness with Crolom (cromolyn sodium ophthalmic solution, 4%)

A trial by a Dr. Di Nardo using mice has found that cromolyn sodium ophthalmic solution 4% is able to reduce skin redness. This small trial, which will be double blinded seeks to see whether the effect can be replicated in humans. A total of 10 patients will be given either the saline vehicle or […]

Continue Reading

Will I have a Bad Reaction to Mirvaso?

Now that Mirvaso has been officially approved by the FDA, the final clinical trial results quoted to the FDA have become available. The Mirvaso Prescribing Information contains some statistics relating to the number and type of adverse reactions that occurred during the clinical trials. So if you are prescribed Mirvaso, what are your chances that […]

Continue Reading

 

Top

Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.